HARD

product on market Capsule Core Nutritionals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains KSM-66 Ashwagandha and L-Theanine, which have moderate to strong evidence for reducing stress and anxiety. Phosphatidylserine and DIM are included for cognitive and hormonal support, though evidence for these specific applications is more limited. The overall profile focuses on cortisol management and mood regulation.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for HARD
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
28
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 450.0mg (502 products) 28 studies (A:0, B:8)
Market median: 100.0mg (108 products)
300 mg
Market median: 200.0mg (358 products) 9 studies (A:0, B:2)
Market median: 200.0mg (3 products) 11 studies (A:1, B:3)
Cocoabuterol
100 mg

Other Ingredients

Rice Flour Cellulose Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 1 capsule 3 times per day. For optimal results, take 1 capsule upon waking, 1 capsule midday, and 1 capsule before bed or take all 3 capsules before bed. Do not exceed 4 capsules in a 24 hour period.

Warnings & Precautions

Warning: Consuming this product can expose you to chemicals including lead, which is known to the state of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

Warning: This product is only intended for use in healthy adults 18 years of age or older. Keep out of reach of children.

Pregnant or nursing women should not use this product. Consult your healthcare provider before using this product, especially if you are taking any prescription, over the counter medication, dietary supplement product, or if you have any pre-existing medical condition including but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart, liver, kidney or thyroid disease, seizure disorder, psychiatric disease, diabetes, difficulty urinating due to prostate enlargement or if you are taking a MAOI (Monoamine Oxidase Inhibitor) or any other medication.

Discontinue use and consult your health care professional if you experience adverse reaction to this product. Discontinue use 2 weeks prior to surgery. Do not exceed recommended serving. Do not use if safety seal is broken or missing.

Allergen Information: Contains ingredient derived from soy.

Formulation Notes

Core HARD redefines recomposition with an advanced and synergistic blend of highly effective ingredients. Key ingredients in Core HARD were shown to: Reduce measurements of cortisol by 27% in a clinical trial in humans. Help balance the enzymes involved in estrogen metabolism. Increase performance and reduce perception of stress in healthy athletes.

Advanced recomposition and hardening agent Balance Harden Recomp

Manufactured in a U.S. cGMP facility.

Additional Information

Servings per container: 28 (days)

Metadata

Product Details

UPC / SKU6 72975 31528 3
DSLD Entry Date2023-10-24
Product TypeOther Combinations
FormCapsule
DSLD ID298087
Data Updated2026-04-11
Research

Research Evidence

63
Research Sources
54
Avg Quality
26
Systematic Review
21
Rct
11
Meta Analysis
5
Clinical Trial
B Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review
Systematic Review Lupus science & medicine 2025 PubMed DOI
B Effects of Ashwagandha (Withania somnifera) on VO2max: A Systematic Review and Meta-Analysis
Meta Analysis Nutrients 2020 PubMed DOI
B Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Phytotherapy research : PTR 2022 PubMed DOI
B An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
Meta Analysis Psychological medicine 2019 PubMed DOI
B Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta-analysis
Meta Analysis Human psychopharmacology 2024 PubMed DOI
B Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis
Meta Analysis PloS one 2021 PubMed DOI
B Plant-derived nootropics and human cognition: A systematic review
Systematic Review Critical reviews in food science and nutrition 2023 PubMed DOI
B Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis
Meta Analysis Explore (New York, N.Y.) 2024 PubMed DOI
B Systematic review and network meta-analysis of the effects of plant active substance on quality of life in breast cancer patients
Systematic Review Frontiers in pharmacology 2025 PubMed DOI
B Clinical evidence for the adaptogenic effects of Withania somnifera and Rhodiola rosea - A systematic review with molecular interpretation of psychometric outcomes
Systematic Review Annals of agricultural and environmental medicine : AAEM 2026 PubMed DOI
View all evidence for Ashwagandha →
Compare

Similar Products

View all Ashwagandha products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.